Vigabatrin
HealthData.Gov
Updated Jun 12, 2026
About this dataset
Vigabatrin is a prescription medication used to treat certain types of epilepsy. This generic oral tablet, containing 500 mg of vigabatrin per dose, is manufactured by Hikma Pharmaceuticals USA Inc. and approved under application number ANDA213104. It works as an anti-epileptic agent to help control seizures. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Vigabatrin
Access the FDA dataset for Vigabatrin β ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025